An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Reelin and glutamic acid decarboxylase (GAD) 67 expressed by cortical γ-aminobutyric acid-ergic interneurons are down-regulated in schizophrenia. Because epidemiological studies of schizophrenia fail to support candidate gene haploinsufficiency of Mendelian origin, we hypothesize that epigenetic mechanisms (i.e., cytosine hypermethylation of CpG islands present in the promoter of these genes) may be responsible for this down-regulation. Protracted l -methionine (6.6 mmol/kg for 15 days, twice a day) treatment in mice elicited in brain an increase of S -adenosyl-homocysteine, the processing product of the methyl donor S -adenosyl-methionine, and a marked decrease of reelin and GAD 67 mRNAs in both WT and heterozygous reeler mice. This effect of l -methionine was associated with an increase in the number of methylated cytosines in the CpG island of the reelin promoter region. This effect was not observed for GAD 65 or neuronal-specific enolase and was not replicated by glycine doses 2-fold greater than those of l -methionine. Prepulse inhibition of startle declined at a faster rate as the prepulse/startle interval increased in mice receiving l -methionine. Valproic acid (2 mmol/kg for 15 days, twice a day) reverted l -methionine-induced down-regulation of reelin and GAD 67 in both WT and heterozygous reeler mice, suggesting an epigenetic action through the inhibition of histone deacetylases. The same dose of valproate increased acetylation of histone H3 in mouse brain nearly 4-fold. This epigenetic mouse model may be useful in evaluating drug efficacy on schizophrenia vulnerability. Hence the inhibition of histone deacetylases could represent a pharmacological intervention mitigating epigenetically induced vulnerability to schizophrenia in individuals at risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CpG Islands in vertebrate genomes
Gardiner-Garden, M., & Frommer, M. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90689-9 · Cited by 3,353
High sensitivity mapping of methylated cytosines
Susan, J. C., Harrison, J., Paul, C. L., & Frommer, M. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.15.2990 · Cited by 1,862
Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758
A protein related to extracellular matrix proteins deleted in the mouse mutant reeler
D'Arcangelo, G., G. Miao, G., Chen, S.-C., Scares, H. D., Morgan, J. I., & Curran, T. (1995) · Nature · doi:10.1038/374719a0 · Cited by 1,748
Decreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia
Glantz, L. A., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.65 · Cited by 1,636
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
Johnstone, R. W. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd772 · Cited by 1,515
Guidotti, A., Auta, J., Davis, J. M., Gerevini, V. D., Dwivedi, Y., Grayson, D. R., Impagnatiello, F., Pandey, G., Pesold, C., Sharma, R., et al. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.11.1061 · Cited by 1,206
Self-citationAkbarian, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160008002 · Cited by 1,002
The reduced neuropil hypothesis: a circuit based model of schizophrenia
Selemon, L. D., & Goldman-Rakic, P. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00281-9 · Cited by 909
Bisulfite genomic sequencing: systematic investigation of critical experimental parameters
Grunau, C. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.13.e65 · Cited by 789
Volk, D. W., Austin, M. C., Pierri, J. N., Sampson, A. R., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.3.237 · Cited by 697
Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning
Weeber, E. J., Beffert, U., Jones, C., Christian, J. M., Förster, E., Sweatt, J. D., & Herz, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205147200 · Cited by 623
A common mechanism of action for three mood-stabilizing drugs
Williams, R. S. B., Cheng, L., Mudge, A. W., & Harwood, A. J. (2002) · Nature · doi:10.1038/417292a · Cited by 618
Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action
Löscher, W. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00075-6 · Cited by 532
DNA methylation and chromatin – unraveling the tangled web
Robertson, K. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205609 · Cited by 471
Tohen, M., Chengappa, K. N. R., Suppes, T., Zarate, C. A., Calabrese, J. R., Bowden, C. L., Sachs, G. S., Kupfer, D. J., Baker, R. W., Risser, R. C., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.1.62 · Cited by 463
On the epigenetic regulation of the human reelin promoter
Chen, Y. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf401 · Cited by 274
Anti‐tumor mechanisms of valproate: A novel role for an old drug
Blaheta, R. A., & Cinatl, J. (2002) · Medicinal Research Reviews · doi:10.1002/med.10017 · Cited by 269
Liu, W. S., Pesold, C., Rodriguez, M. A., Carboni, G., Auta, J., Lacor, P., Larson, J., Condie, B. G., Guidotti, A., & Costa, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051614698 · Cited by 226
Self-citationThe phenotypic characteristics of heterozygous reeler mouse
Tueting, P., Costa, E., Dwivedi, Y., Guidotti, A., Impagnatiello, F., Manev, R., & Pesold, C. (1999) · NeuroReport · doi:10.1097/00001756-199904260-00032 · Cited by 220
Self-citationCosta, E., Davis, J., Grayson, D. R., Guidotti, A., Pappas, G. D., & Pesold, C. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0436 · Cited by 195
Self-citationRodriguez, M. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050589797 · Cited by 176
Cervoni, N., Detich, N., Seo, S.-B., Chakravarti, D., & Szyf, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202256200 · Cited by 175
Müller-Oerlinghausen, B., Retzow, A., Henn, F. A., Giedke, H., & Walden, J. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200004000-00012 · Cited by 170
REELIN and Schizophrenia:: A Disease at the Interface of the Genome and the Epigenome
Costa, E. (2002) · Molecular Interventions · doi:10.1124/mi.2.1.47 · Cited by 126
Self-citationImpagnatiello, F., Pesold, C., Longone, P., Caruncho, H., Fritschy, J. M., Costa, E., & Guidotti, A. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09071-6 · Cited by 124
Self-citationLacor, P. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050589597 · Cited by 110
The heterozygote reeler mouse as a model for the development of a new generation of antipsychotics
Costa, E., Davis, J. M., Pesold, C., Tueting, P. A., & Guidotti, A. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00121-7 · Cited by 109
Self-citationDetection of the reelin breakpoint in reeler mice
D’Arcangelo, G., Miao, G. G., & Curran, T. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(96)00046-0 · Cited by 95
Genomic Organization of the MouseReelinGene
Royaux, I. E., de Rouvroit, C. L., D’Arcangelo, G., Demirov, D. G., & Goffinet, A. M. (1997) · Genomics · doi:10.1006/geno.1997.4983 · Cited by 91
The effects of L-methionine (without MAOI) in schizophrenia
Antun, F., Burnett, G. B., Cooper, A. J., Daly, R. J., Smythies, J., & Zealley, A. K. (1971) · Journal of Psychiatric Research · doi:10.1016/0022-3956(71)90009-4 · Cited by 80
Wyatt, R. J., Termini, B. A., & Davis, J. (1971) · Schizophrenia Bulletin · doi:10.1093/schbul/1.4.10 · Cited by 75
Rosoklija, G., Toomayan, G., Ellis, S. P., Keilp, J., Mann, J. J., Latov, N., Hays, A. P., & Dwork, A. J. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.4.349 · Cited by 1
Cited by
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Epigenetic regulation in psychiatric disorders
Tsankova, N., Renthal, W., Kumar, A., & Nestler, E. J. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2132 · Cited by 1,400
“There is mounting evidence that epigenetic mechanisms are involved in the pathogenesis of schizophreni”
BackgroundTissir, F., & Goffinet, A. M. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1113 · Cited by 751
Maternal care as a model for experience-dependent chromatin plasticity?
Meaney, M. J., & Szyf, M. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.07.006 · Cited by 658
Is folic acid good for everyone?
Smith, A. D., Kim, Y.-I., & Refsum, H. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.3.517 · Cited by 612
Metadata
- Authors
- Tremolizzo, L., Carboni, G., Ruzicka, W. B., Mitchell, C. P., Sugaya, I., Tueting, P., Sharma, R., Grayson, D. R., Costa, E., & Guidotti, A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-12-12
- Volume
- 99
- Issue
- 26
- Pages
- 17095-17100
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1971334707
- Cited by
- 384
- References
- 33
- FWCI
- 12.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.